Evidence map›Paper›PMID 28262549›Full record

Trial reportEBioMedicine2017

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans.

Nora E Zois, Dijana Terzic, Kristine Færch, Peter Plomgaard, Jakob S Hansen, Peter Rossing, Jens P Goetze

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in EBioMedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Nora E ZoisDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
Dijana TerzicDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
Kristine FærchSteno Diabetes Center, Gentofte, Denmark.
Peter PlomgaardDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Jakob S HansenDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Peter RossingSteno Diabetes Center, Gentofte, Denmark; Faculty of Health, Aarhus University, Aarhus, Denmark; Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Jens P GoetzeDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark; Faculty of Health, Aarhus University, Aarhus, Denmark; Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: JPG@dadlnet.dk.
Rigshospitalet · DKAarhus University · DKSteno Diabetes Centers · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma concentrations of pro-Atrial natriuretic peptide, proANP, are decreased in obesity and diabetes. Decreased proANP concentrations have also been noted after meal intake, and recently, a glucose-mediated regulation of ANP gene expression was reported. Hence, we evaluated the effects of insulin, glucagon and glucose on plasma proANP in a series of observational and experimental studies. Six healthy men underwent seven days of bed rest. Before and after the bed rest, hyperinsulinemic euglycemic clamps with serial plasma measurements of proANP were performed. Moreover, plasma proANP was quantified in 65 individuals with normal or impaired glucose regulation. Finally, the effects of infusion-induced hyperglucagonemia were examined in ten healthy men. Bed rest decreased insulin sensitivity and plasma proANP. The decrease in proANP was not associated with insulin sensitivity and the peptide concentrations remained constant during euglycemic hyperinsulinemia and hyperglycemic hyperglucagonemia. Impaired glucose regulation was not associated with decreased proANP concentrations. Bed rest per se induces a marked decrease in plasma proANP concentrations whereas insulin resistance and impaired glucose regulation was not associated with lower proANP concentrations. Neither acute hyperinsulinemia nor hyperglucagonemia seems to affect plasma proANP. Our findings thus suggest that decreased plasma proANP concentrations occur late in the development of insulin resistance.

Indexed as

AdultAtrial Natriuretic FactorBed RestBlood GlucoseHumansInsulinInsulin ResistanceMaleAtrial Natriuretic FactorBlood GlucoseInsulinmidregional pro-atrial natriuretic peptide, humanHyperglycemiaInsulin resistanceMetabolismPrediabetesProANP

Identifiers

PMID28262549
PMCPMC5360596
OpenAlexW2592864982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.